Norges Bank’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-314,800
| Closed | -$3.47M | – | 1467 |
|
2024
Q4 | $3.47M | Buy |
+314,800
| New | +$3.47M | ﹤0.01% | 1590 |
|
2024
Q2 | – | Sell |
-50,000
| Closed | -$675K | – | 1982 |
|
2024
Q1 | $675K | Buy |
+50,000
| New | +$675K | ﹤0.01% | 1822 |
|
2023
Q3 | – | Sell |
-24,700
| Closed | -$263K | – | 2028 |
|
2023
Q2 | $263K | Buy |
+24,700
| New | +$263K | ﹤0.01% | 1989 |
|
2023
Q1 | – | Sell |
-394,312
| Closed | -$3.64M | – | 2161 |
|
2022
Q4 | $3.64M | Buy |
394,312
+199,900
| +103% | +$1.85M | ﹤0.01% | 1868 |
|
2022
Q3 | $2.5M | Hold |
194,412
| – | – | ﹤0.01% | 1878 |
|
2022
Q2 | $2.57M | Buy |
194,412
+48,812
| +34% | +$645K | ﹤0.01% | 1867 |
|
2022
Q1 | $3.06M | Buy |
+145,600
| New | +$3.06M | ﹤0.01% | 1931 |
|
2021
Q4 | – | Sell |
-45,200
| Closed | -$1.15M | – | 2287 |
|
2021
Q3 | $1.15M | Buy |
+45,200
| New | +$1.15M | ﹤0.01% | 2132 |
|
2019
Q4 | – | Sell |
-25,000
| Closed | -$537K | – | 2093 |
|
2019
Q3 | $537K | Hold |
25,000
| – | – | ﹤0.01% | 2059 |
|
2019
Q2 | $729K | Buy |
+25,000
| New | +$729K | ﹤0.01% | 2048 |
|